U.S. patent application number 10/035561 was filed with the patent office on 2002-09-19 for graft polymerization of substrate surfaces.
Invention is credited to Wang, Guo-Bin, Zhang, Xianping.
Application Number | 20020133072 10/035561 |
Document ID | / |
Family ID | 23559541 |
Filed Date | 2002-09-19 |
United States Patent
Application |
20020133072 |
Kind Code |
A1 |
Wang, Guo-Bin ; et
al. |
September 19, 2002 |
Graft polymerization of substrate surfaces
Abstract
The invention includes a method of coating a substrate,
comprising exposing a substrate to an initiator capable of
initiating a graft polymerization reaction on the substrate, to
generate reactive radical sites on the surface of the substrate;
contacting the substrate with a composition comprising one or more
monomers in a medium which has different hydrophilicity compared to
the substrate, and grafting monomer molecules onto the substrate by
forming covalent bonds between monomer molecules and the substrate
at reactive radical sites on the substrate surface. With the
invention, novel coated articles can be obtained which are
particularly useful as medical products such as catheters.
Inventors: |
Wang, Guo-Bin; (Rochester,
NY) ; Zhang, Xianping; (Webster, NY) |
Correspondence
Address: |
KENYON & KENYON
ONE BROADWAY
NEW YORK
NY
10004
US
|
Family ID: |
23559541 |
Appl. No.: |
10/035561 |
Filed: |
November 7, 2001 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
10035561 |
Nov 7, 2001 |
|
|
|
09394577 |
Sep 10, 1999 |
|
|
|
6358557 |
|
|
|
|
Current U.S.
Class: |
600/423 ;
427/314; 427/337; 604/249 |
Current CPC
Class: |
B05D 1/18 20130101; A61L
29/085 20130101 |
Class at
Publication: |
600/423 ;
427/314; 427/337; 604/249 |
International
Class: |
B05D 003/02; B05D
003/10; C08J 007/18; C04B 041/00; A61M 005/00; A61B 005/05 |
Claims
What is claimed is:
1. A method of coating a substrate, comprising: exposing a
substrate to an initiator capable of initiating a graft
polymerization reaction on the substrate, to generate reactive
radical sites on the surface of the substrate; contacting the
substrate with a composition comprising one or more monomers in a
medium which has reversed phase properties compared to the
substrate, in terms of hydrophilicity; and graft polymerizing onto
the substrate by forming covalent bonds between monomer molecules
and the substrate it reactive radical sites on the substrate
surface.
2. The method of claim 1, further comprising mixing the composition
so that a plurality of said molecules remain in proximity to said
reactive radical site.
3. The method of claim 1, wherein the monomers are grafted onto the
substrate at a pressure less than about 50 atmospheres.
4. The method of claim 1, wherein the monomers are grafted onto the
substrate at a temperature from about 10.degree. C. to about
100.degree. C.
5. The method of claim 1, wherein the substrate is selected from
the group consisting of solid synthetic polymers and solid natural
polymers.
6. The method of claim 5, wherein the substrate is selected from
the group consisting of polyolefin, silicone polymer, acrylic
polymer, acrylic copolymer, polyesteracrylate,
polyestermethacrylate, fluoropolymer, vinyl polymer, vinyl
monomer-containing copolymer, natural rubber, synthetic rubber,
polyurethane, polyamide, polyester, epoxy polymer, wool, cotton,
silk, rayon, and cellulose.
7. The method of claim 6, wherein the substrate is selected from
the group consisting of polyethylene, polypropylene,
polyisobutylene, ethylene-alphaolefin copolymer, polyacrylonitrile,
polymethylmethacrylate, polyethylmethacrylate, polyethylacrylate,
polytetrafluoroethylene, chlorotrifluoroethylene, fluorinated
ethylene-propylene, polyvinyl fluoride, polyvinyl chloride,
polyvinyl methyl ether, polystyrene, polyvinyl acetate, polyvinyl
ketone, ABS, latex rubber, butadiene-styrene copolymer,
polyisoprene, polybutadiene, butadiene-acrylonitrile copolymer,
polychloroprene polymer, polyisobutylene rubber,
ethylene-propylenediene copolymer, polyisobutylene-isoprene,
polyetherurethane, polyesterurethane, polycarbonateurethane and
polysiloxaneurethane, Nylon 6, Nylon 66, Nylon 10, Nylon 11,
modified cellulose, polyacrylamide, poly2-hydroxyethylacryl- ate,
polyN,N'-dimethylacrylamide, polyacrylic acid, polymethacrylic
acid, polyN-vinylpyrrolidone, polyvinylpyridine, polymaleic acid,
poly2-hydroxyethyl fumarate, maleic anhydride, starch, and
polyvinyl alcohol.
8. The method of claim 1, wherein the medium is a hydrophilic
aqueous solution.
9. The method of claim 8, wherein the medium contains one or more
ions selected from the group consisting of sodium, ammonium,
potassium, chloride, phosphate, and acetate buffers.
10. The method of claim 1, wherein the medium is hydrophobic, and
comprises an organic solvent.
11. The method of claim 10, wherein the medium comprises a solvent
selected from the group consisting of toluene, hexane, cyclohexane,
and mixtures thereof.
12. The method of claim 1, wherein the initiator is selected from
the group consisting of peroxide initiators, azo initiators, redox
initiators, and photo-initiators/photosensitizers which can be
thermally initiated.
13. The method of claim 12, wherein the initiator is a peroxide
initiator selected from the group consisting of peroxyester,
peroxyketal, peroxydicarbonate, ketone peroxide, dialkyl peroxide,
diacyl peroxide, an inorganic peroxide, and mixtures thereof.
14. The method of claim 13, wherein the initiator is selected from
the group consisting of 1,1-dimethyl-3-hydroxybutyl
peroxyneodecanoate, .alpha.-cumyl peroxyneodecanoate, .alpha.-cumyl
peroxyneoheptanoate, t-amyl peroxyneodecanoate, t-butyl
peroxyneodecanoate, t-amyl peroxypivalate, t-butyl peroxypivalate,
2,5-dimethyl 2,5-di(2-ethylhexanoylperoxy)hexane,
t-butylperoxy-2-ethylhexanoate, t-butylperoxyacetate,
t-amylperoxyacetate, t-butylperbenzoate, t-amylperbenzoate,
t-butyl-1-(2-ethylhexyl)monoperoxycarbonate,
1,1-di(t-butylperoxy)-3,3,5-trimethyl-cyclohexane,
1,1-di(t-butylperoxy)-cyclohexane,
1,1-di(t-amylperoxy)-cyclohexane,
ethyl-3,3-di(t-butylperoxy)-butyrate,
ethyl-3,3-di(t-amylperoxy)-butylper- oxy)-butylrate,
di(n-propyl)peroxydicarbonate, di(sec-butyl)perosydicarbon- ate,
di(2-ethylhexyl)peroxydicarbonate, 2,4-pentanedione peroxide,
cumene hydroperoxide, butyl hydroperoxide, amyl hydroperoxide,
dicumyl peroxide, dibutylperoxide, diamylperoxide, decanoyl
peroxide, lauroyl peroxide, benzoyl peroxide, hydrogen peroxide,
potassium persulfate, and mixtures thereof.
15. The method of claim 12, wherein the initiator is an azo
initiator selected from the group consisting of
azobisisobutyronitrile, azobiscumene,
azo-bisiso-1,1,1-tricyclopropylmethane,
4-nitrophenyl-azo-triphenylmethane phenyl-azo-triphenylmethane, and
mixtures thereof.
16. The method claim 12, wherein the initiator is a redox initiator
selected from the group consisting of peroxide-amine systems,
peroxide-metal ion systems, and boronalkyl-oxygen systems.
17. The method of claim 12, wherein the initiator is selected from
the group consisting of 1,1-dimethyl-3-hydroxybutyl
peroxyneodecanoate, .alpha.-cumyl peroxyneodecanoate,
(.alpha.-cumyl peroxyneoheptanoate, t-amyl peroxyneodecanoate,
t-butyl peroxyneodecanoate, t-amyl peroxypivalate, t-butyl
peroxypivalate, 2,5-dimethyl 2,5-di(2-ethylhexanoylperoxy)hexane,
t-butylperoxy-2ethylhexanoate, t-butylperoxyacetate,
t-amylperoxyacetate, t-butylperbenzoate, t-amylperbenzoate,
t-butyl-1-(2-ethylhexyl)monoperoxycarbonate,
1,1-di(t-butylperoxy)-3,3,5-trimethyl-cyclohexane,
1,1-di(t-butylperoxy)-cyclohexane,
1,1-di(t-amylperoxy)-cyclohexane,
ethyl-3,3-di(t-butylperoxy)-butyrate,
ethyl-3,3-di(t-amylperoxy)-butylper- oxy)-butylrate,
di(n-propyl)peroxydicarbonate, di(sec-butyl)peroxydicarbon- ate,
di(2-ethylhexyl)perosydicarbonate, 2,4-pentanedione peroxide,
cumene hydroperoxide, butyl hydroperoxide, amyl hydroperoxide,
dicumyl peroxide, dibutylperoxide, diamylperoxide, decanoyl
peroxide, lauroyl peroxide, benzoyl peroxide,
azobisisobutyronitrile, azobiscumene,
azo-bisiso-1,1,1-tricyclopropylmethane,
4-nitrophenyl-azo-triphenylmethan- e, phenyl-azo-triphenylmethane,
benzophenone, benzophenone derivatives, camphorquinone-N,N
dimethyl-amino-ethyl-methacrylate, and mixtures thereof.
18. The method of claim 1, wherein the monomer is selected from the
group consisting of hydrophilic monomers and hydrophobic
monomers.
19. The method of claim 18, wherein the monomer comprises a
hydrophilic monomer selected from the group consisting of hydroxyl
substituted ester acrylate, ester methacrylate,
2-hydroxyethylacrylate, 2-hydroxypropylacrylate,
3-hydroxypropylacrylate, 2,3-dihydroxypropylacry- late,
polyethoxyethylacrylate, polyethoxypropylacrylate, acrylamide,
methacrylamide, N-methylacrylamide, N,N-dimethylacrylamide,
N,N-dimethylmethacrylamide, N,N-dimethyl-aminoethyl,
2-acrylamido-2-methyl-1-propanesulfonic acid,
N,N-diethyl-aminoethyl, 2-acrylamido-2-methyl-1-propanesulfonic
acid, N-[3-dimethylamino)propyl]a- crylamide,
2-(N,N-diethylamino)ethyl methacrylamide, polyethylene glycol
acrylate, polyethylene glycol methacrylate, polyethylene glycol
diacrylate, polyethylene glycol dimethacrylate; poly propylene
glycol acrylate, polypropylene glycol methacrylate, polypropylene
glycol diacrylate, polypropylene glycol dimethacrylate; acrylic
acid, methacrylic acid, 2- and 4-vinylpyridine; 4- and
2-methyl-5-vinylpyridine- , N-methyl-4-vinylpiperidine,
2-methyl-1-vinylimidazole, dimethylaminoethyl vinyl ether,
N-vinylpyrrolidone, itaconic acid, crotonic acid, fumaric acid,
maleic acid, and mixtures thereof.
20. The method of claim 18, wherein the monomer comprises a
hydrophobic monomer selected from the group consisting of ester
acrylates selected from the group consisting of methyl, ethyl,
propyl, butyl, phenyl, benzyl, cyclohexyl, ethoxyethyl,
methoxyethyl, ethoxypropyl, hexafluoroisopropyl and
n-octyl-acrylates; ester methacrylates selected from the group
consisting of methyl, ethyl, propyl, butyl, phenyl, benzyl,
cyclohexyl, ethoxyethyl, methoxyethyl, ethoxypropyl,
hexafluoroisopropyl and n-octyl-methacrylates; acrylamides;
methacrylamides; dimethyl fumarate; dimethyl maleate; diethyl
fumarate; methyl vinyl ether; ethoxyethyl vinyl ether; vinyl
acetate; vinyl propionate; vinyl benzoate; acrylonitrile; styrene;
alpha-methylstyrene; 1-hexene; vinyl chloride; vinyl methyl ketone;
vinyl stearate; 2-hexene; 2-ethylhexyl methacrylate, and mixtures
thereof.
21. A method of coating a substrate, comprising: exposing a
substrate to an initiator capable of initiating a graft
polymerization reaction on the substrate, to generate reactive
radical sites on the surface of the substrate; contacting the
substrate with a composition comprising one or more monomers in a
medium which has reversed phase properties compared to the
substrate, in terms of hydrophilicity, while mixing the
composition; graft polymerizing onto the substrate by forming
covalent bonds between monomer molecules and the substrate at
reactive radical sites on the substrate surface; and contacting the
substrate with a cross-linking agent.
22. The method of claim 21, wherein the cross-linking agent is
selected from the group consisting monomers having di- or
multi-unsaturated functional groups.
23. The method of claim 22, wherein the cross-linking agent is
selected from the group consisting of diacrylates of polyethylene
glycol, diacrylates of polypropylene glycol, dimethylacrylates of
polyethylene glycol, dimethylacrylates of polypropylene glycol,
trimethylolpropane triacrylate, trimethylolpropane trimethacrylate,
di-trimethylolpropane, tetraacrylate, pentaerythritol
tetraacrylate, tetramethacrylate, divinylbenzene, divinyl sulfone,
silicone-containing diacrylates and dimethacrylates, and mixtures
thereof.
24. The method of claim 1, wherein the substrate is silicone; the
initiator is an organic peroxide solution in tetrahydrofuran (THF);
the medium comprises from about 3% w/w to about 6% w/w acrylamide
derivatives, from about 0.1% w/w to about 0.4% w/w diacrylate
crosslinker, from about 10% w/w to about 20% w/w sodium chloride
and from about 0.01% w/w to about 0.03% w/w polyvinylpyrrolidone;
and, the reaction is allowed to proceed at a temperature from about
80.degree. C. to about 95.degree. C. at atmospheric pressure.
25. The method of claim 1, wherein the substrate is silicone; the
initiator is an organic peroxide solution in tetrahydrofuran (THF);
the medium comprises from about 1.0% w/w to about 3.0% w/w
acrylamide derivatives, from about 3.0% w/w to about 5% w/w
polyethylene glycol acrylate, from about 10% w/w to about 20% w/w
sodium chloride and from about 1.0% w/w to about 3.0% w/w
polyvinylpyrrolidone; and the reaction is allowed to proceed at a
temperature from about 80.degree. C. to about 95.degree. C. at
atmospheric pressure.
26. The method of claim 1, wherein the substrate is polyethylene;
the medium comprises from about 20% w/w to about 40% w/w
acrylamide, from about 1% w/w to about 3% w/w polyvinylpyrrolidone,
and from about 10% w/w to about 20% w/w sodium chloride; and the
reaction is allowed to proceed at a temperature from about
80.degree. C. to about 95.degree. C. at atmospheric pressure.
27. The method of claim 1, wherein the substrate is selected from
the group consisting of silicone, polyethylene, polyamide and
latex, and wherein the grafting coats the substrate surface with a
coating having characteristics selected from the group consisting
of lubricious, hydrophilic and elastic properties.
28. The method of claim 1, further comprising attaching to the
coated substrate a biological agent selected from the group
consisting of penicillins, cephalosporins, fluoroquinolones,
aminoglycosides, silver compounds, phenols, and biguanides.
29. A method of coating a substrate, comprising: exposing a
substrate to an initiator capable of initiating a graft
polymerization reaction on the substrate, to generate reactive
radical sites on the surface of the substrate; contacting the
substrate with a composition comprising one or more monomers in a
medium; and graft polymerizing onto the substrate at a pressure
less than about 50 atmospheres by forming covalent bonds between
monomer molecules and the substrate at reactive radical sites on
the substrate surface.
30. The method of claim 29, wherein said graft polymerization is
accomplished at a pressure less than about 10 atmospheres.
31. A medical device comprising: a substrate constructed and
arranged for insertion into a patient; and a plurality of monomer
molecules graft polymerized onto the surface of the substrate from
a medium having reversed phase properties from the substrate, in
terms of hydrophilicity.
32. A medical device according to claim 31, wherein the substrate
is selected from the group consisting of guide wires, and catheters
selected from the group consisting of PTCA catheters, cardiology
catheters, central venous catheters, urinary catheters, drain
catheters, and dialysis catheters.
33. A medical device according to claim 31, wherein the substrate
defines at least one lumen, at least a portion of which is coated
with monomer molecules graft polymerized to the lumen surface.
34. A medical device according to claim 33, wherein the substrate
defines both interior and exterior surfaces of a lumen, and at
least a portion of both the interior and exterior of the lumen is
coated with monomer molecules graft polymerized to the lumen
surface.
35. A system for forming a graft polymerized medical device
comprising: a substrate constructed and arranged for insertion into
a patient; an initiator capable of initiating a graft
polymerization reaction on the substrate, to generate reactive
radical sites on the surface of the substrate; and a composition
comprising one or more monomers in a medium which has reversed
phase properties compared to the substrate, in terms of
hydrophilicity.
Description
FIELD OF THE INVENTION
[0001] The present invention relates to methods for grafting
polymers and copolymers onto polymer substrates.
BACKGROUND OF THE INVENTION
[0002] It is desirable for substrates such as those used in certain
medical devices, including but not limited to catheters and tubes
which are inserted into blood vessels, body cavities or tissues, or
into the respiratory tract including the trachea, or inserted
through other catheters or tubes, to have smoothness to ensure that
such devices may be introduced without causing trauma to tissue
encountered during their placement. The surfaces may be further
enhanced by having lubricity for preventing injury or inflammation
of mucous membranes or other surrounding tissues that may be caused
when the devices remain in place.
[0003] In some instances, it is advantageous for medical device
surfaces to have the capability to serve as a depot for various
physiologically or pharmacologically active agents.
Antithrombogenic materials, such as complexes of heparin with
quaternary ammonium compounds, have been used on medical device
surfaces to prevent thrombus formation on the surface of a medical
device, as described in U.S. Pat. No. 5,069,899. In order to
control nosocomial infections, anti-microbial agents including
penicillins, cephalosporins, fluoroquinolones, aminoglycosides,
silver compounds, phenols, biguanides, and others, have been
proposed for use in surface coatings on the surfaces of implanted
prostheses, as described in U.S. Pat. Nos. 5,069,899 and
4,442,133.
[0004] Many of the plastic materials of which such devices are
ordinarily constructed are not easily treated with conventional
surface enhancing methods. Materials used to make catheters are
mostly hydrophobic and resist to one degree or another treatments
designed to make them more biocompatible. Polymers such as
silicones, latex rubbers, polyolefins, and many polyesters and
polyamides have very low surface energies, often less than 40
dynes/cm.sup.2. Furthermore, these surfaces are often very
resistant to dissolution in or swelling by solvents that ordinarily
are used in the coating industry. Also, these surfaces often lack
functional groups susceptible to interactions such as hydrogen
bonding or Van der Waals forces, which are commonly utilized to
promote improved adhesion of surface layers. Technologies that have
been proposed to overcome these shortcomings fail to address a
number of the difficulties associated with the surface treatment of
such medical devices.
[0005] Flame treatments are widely applied in surface modification
to introduce oxygen-containing functions at polyolefin surfaces,
mainly to improve printability or paintability. (F. Garbassi, M.
Morra, E. Occhiello, Polymer Surfaces, From Physics to Technology,
John Wiley & Sons, Chichester, (1994)). Active species formed
by the high temperatures include radicals, ions, and molecules in
excited states. Such treatments have not been used widely in the
medical device industry. The harsh conditions of flame treatments
generally could be harmful to the relatively fragile devices, and
they have not been useful in treating device lumens.
[0006] Corona treatments exploit the corona affect, i.e. the
formation of high energy electromagnetic fields close to thin wires
or points, with consequent ionization in their proximity, even at
atmospheric pressure and relatively low temperatures. Excited
species (ions, radicals, electrons, molecules in excited states,
etc.) are present in the ionized region, and are active in surface
modification, typically the introduction of oxygen-containing
functions. (F. Garbassi, M. Morra, E. Occhiello, Polymer Surfaces,
From Physics to Technology, John Wiley & Sons, Chichester,
(1994)). Although this process may be suitable for treating film
webs, it is not suitable for treating device lumens and has not
found wide application in the medical device industry.
[0007] "Cold Plasma" treatments require low pressure to be
sustained at low temperatures. An ionized region is formed,
including high energy photons, electron, ions, radicals, and
excited species, with its composition depending on a gas feed. Low
pressure plasmas can be employed for surface activation by the
introduction of oxygen-containing functional groups, etching by
formation of gaseous species (e.g., carbon oxides or fluorides in
CF.sub.3/O.sub.2 plasmas), or coating deposition by plasma
polymerization (e.g., of fluorine or silicon-containing monomers).
(F. Garbassi, M. Morra, E. Occhiello, Polymer Surfaces, From
Physics to Technology, John Wiley & Sons, Chichester, (1994)).
Cold plasma treatments have been used in the medical device
industry but generally have not been effective at treating device
lumens that are long or of small diameter.
[0008] "Hot Plasma" treatments are performed at atmospheric
pressure at very high temperatures (5,000 to 10,000.degree. K.).
While these treatments have gained widespread use in the metallurgy
industry, they generally are not useful with polymeric medical
devices because of the extremely high temperatures that are
required.
[0009] Ultraviolet (UV) treatments employ photons, usually having
low wavelength and high energy, which are used to activate a
variety of chemical reactions. A typical example of UV action on
polymer surfaces is surface degradation by sun exposure. UV lamps
have been used for the treatment of polymer surfaces, with the
apparatus involving a lamp and sample illumination devices. A
review of literature on UV-cured coatings can be found in C. -M.
Chan, T. -M. Ko, and H. Hiraoka, Surf. Sci. Rep., 24,1 (1996), and
R. R. Rye, J. Polym. Sci. Phys. Ed. 26, 2133 (1988). UV-induced
graft polymerization is used to treat and modify medical devices.
However such treatment has limited application. Many medical
devices are deliberately treated to make them opaque to such
radiation, and it is difficult to treat device lumens, especially
smaller, longer lumens, unless the device is transparent to the UV
radiation.
[0010] Free radical graft copolymerization has been used to modify
material surfaces. Highly reactive free radical transferring
creates reactive radical sites on the substrate surface, which are
able to initiate copolymerization with available monomers, or
reactive oligomers, thereby generating a graft polymer layer. Two
major difficulties with such an approach are the ability to create
a substantial number of substrate radicals, and to significantly
reduce the amount of homopolymerization initiated by initiator
radicals along with the graft copolymerization. (M. P. Stevens,
Polymer chemistry: an introduction, Addison-Wesley, London
(1975)).
[0011] Graft polymerization of medical catheters and other medical
devices has been utilized to provide surfaces having different
properties from the bulk polymers forming the body of the device.
Such treatments typically use plasma or UV as a source of energy to
promote the graft polymer formation and attendant covalent bonding
to the surface.
[0012] In U.S. Pat. No. 5,447,799, Loh, et al. describe a process
for depositing polymeric materials on surfaces, first by providing
a layer of polymeric material on the surface by glow discharge
polymerization of a mixture of silane and a vaporizable hydrocarbon
monomer or a vaporizable organosilane monomer, and then providing a
second layer of another polymeric material, on the first polymeric
material, by vapor deposition polymerization of aromatic
hydrocarbons or unsaturated hydrocarbons.
[0013] Kolesinski et al. U.S. Pat. No. 5,211,993 describes a method
of preparing chromatographically active support material by coating
surfaces of a comminuted inorganic substrate material with a
monomer which, when polymerized, has chromatographic properties.
Such monomers are said to include vinyl stearate, polyethylene
glycol 1000 monomethacrylate, and stearyl methacrylate. Such
treatments have the shortcoming of requiring expensive plasma
generating apparatus to modify the device surface.
[0014] U.S. Pat. No. 5,741,551 describes methods for providing a
polymer coating on a solid substrate by applying a coating of
reactive chemicals having photo-activatable ketones covalently
bonded to them, and irradiating with UV light to induce covalent
bonding of the reactive chemicals to the substrate, followed by
reacting a layer of monomer, oligomer, or polymer with the
covalently bound reactive chemicals to produce a polymeric layer
which is covalently bound to the substrate. U.S. Pat. No. 5,002,582
describes a method of applying a polymer coating onto a substrate
that involves coating a surface with a mixture of polymer and
polymer having covalently bound photo-activatable groups, and
irradiating the material with UV light to induce covalent bonding
of the coating to the substrate. These methods require radiation
sources and are not suitable for the effective application of lumen
coatings.
[0015] Lee, et al. U.S. Pat. No. 5,663,237 describes that graft
polymer layers can be created on plastic surfaces by heating a
mixture of monomer(s), polymerization initiator, and a
supercritical solvent which is capable of at least superficial
penetration into the device plastic surface in a pressure reactor.
Disadvantages of the method include the need for high pressure and
temperature, the presence of harmful reactive polymerization
initiator in the graft polymer layer, the need for "supercritical"
solvents to penetrate the device surface, and the inability to use
the technique on surfaces for which supercritical solvents are
unavailable.
[0016] A need exists for a means of providing polymer coatings on
surfaces, particularly on surfaces such as polyolefins (such as
polyethylene), silicones, polyamides, latex rubber, etc., onto
which it is difficult for conventionally applied coatings to
adhere. There is a particular need for providing polymer coatings
in a convenient, inexpensive manner, and to apply coatings to the
exterior and interior surfaces of devices.
SUMMARY OF THE INVENTION
[0017] The present invention relates to polymeric substrates and
treatments which form polymers and modify the surface properties of
the substrate. The invention includes a method of coating a
substrate, comprising exposing a substrate with an initiator
capable of initiating a graft polymerization reaction on the
substrate; generating reactive radical sites on the surface of the
substrate; contacting the substrate with a composition comprising a
monomer in a medium which optionally has reversed phase properties
compared to the substrate, in terms of hydrophilicity; and grafting
the monomers onto the substrate by forming covalent bonding at
reactive radical sites on the substrate surface, and accomplishing
graft polymerization.
[0018] Preferably, the invention employs a salting out effect to
favor graft polymerization instead of homopolymerization of the
monomers. The invention permits graft polymerization of substrates
at relatively low operating and capital costs, can accommodate
polymerization of substrates of varied shapes, and can be utilized
in relatively large batch operations. The invention is particularly
useful in coating the lumen of polymeric substrates of varying
dimensions, which are useful as medical devices.
[0019] The invention comprises a method of providing a solid
surface with desired characteristics comprising contacting a
substrate with an initiator of similar hydrophilicity as the
substrate, and contacting the substrate with a medium having a
surface tension that differs from the surface energy of the
substrate, and in which the initiator is poorly soluble. Optionally
the medium has reversed phase properties in terms of
hydrophilicity, compared to the substrate. The medium preferably
contains monomers having desired surface characteristics for the
polymer substrate. The medium preferably is subject to mixing
during contact with the substrate, to promote uniform dispersion of
the monomer. The reaction preferably is performed at temperatures
from about 20.degree. C. to about 100.degree. C. and at pressures
from about 0.5 atmosphere to about 50 atmospheres. Optionally, the
medium can contain salts or other materials having a relatively
high solubility in the medium.
[0020] Suitable media include, but are not limited to, organic
solvents and aqueous solutions, optionally containing dissolved
ions or other substances which are very soluble in the medium and
which will encourage graft polymerization. Suitable initiators
include but are not limited to peroxide initiators, azo initiators,
redox initiators, and photo-initiators/photosensitizers/thermal
initiators. Hydrophilic or hydrophobic monomers can be used.
Optionally, one or more cross-linking agents can be employed, such
as cross-linking agents containing di- or multi-unsaturated
functional groups. One embodiment of the present invention
comprises a method of coating a lumen of a device by a reverse
phase graft polymerization method described herein.
[0021] The present invention is applicable to a variety of
substrates, including medical devices comprising silicone,
polyethylene, polyamide and latex. With the invention, such devices
can undergo surface modification by reversed phase graft
polymerization, providing the device with altered surface
characteristics, such as improved lubriciousness, and/or the
ability to serve as a drug reservoir.
[0022] Thus, according to the invention, polymers and copolymers
can be grafted onto polymer substrates to provide a surface with
various functions, including but not limited to hydrophilicity,
lubricity, ability to serve as a primer or tie coat, and ability to
serve as a reservoir for physiologically or pharmacologically
active agents. The reversed-phase graft polymerization of the
instant invention permits hydrophilic polymer coatings on
difficult-to-adhere-to surfaces, is capable of being applied to
both interior an exterior surfaces of devices, and is relatively
convenient and inexpensive.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0023] The invention provides methods for graft polymerization,
preferably reversed-phase graft polymerization, enabling the
grafting of polymers and copolymers onto polymer substrates in
order to serve a variety of functions. Examples include, but are
not limited to, the use of a graft polymer capable of absorbing
large quantities of water in order to provide moisture absorption
or lubricity; the use of the graft polymer as a tie coat in order
to allow succeeding layers to adhere; the use of the graft polymer
to provide functional groups to attach physiologically or
pharmacologically active agents; and the use of the graft polymer
as a drug depot permitting the delivery of various drugs from the
graft polymer. Optionally drugs can be mixed in with the polymer or
bound to the functional groups with ionic forces.
[0024] Devices that could be provided with different surface
characteristics by this method include but are not limited to
medical devices, including but not limited to catheters, guide
wires and medical instruments. Examples include, but are not
limited to, PTCA catheters, cardiology catheters, central venous
catheters, urinary catheters, drain catheters, and dialysis
catheters.
[0025] Properties which can be provided to devices of the invention
include, but are not limited to, hydrophobic coatings on
hydrophilic substrates, hydrophilic coatings on hydrophobic
substrates, non-conductive coatings on conductive surfaces,
conductive coatings on non-conductive surfaces., acidic or basic
coatings on pH-neutral substrates, non-thrombogenic coatings on
thrombogenic substrates, thrombogenic coatings on non-thrombogenic
substrates, and coatings with radio-isotopic magnetic, antibiotic
and anticancer properties. According to the invention, a graft
polymerization is performed by selecting an appropriate initiator
and a polymerization medium, based on the nature of the substrate
and the required surface properties. Appropriate initiators
preferably will orient free radicals to attack the substrate
surface and create the reactive radical sites on the substrate
necessary to initiate graft polymerization. The graft
polymerization generates a surface polymer layer as a surface
coating which adheres well to various substrates, including polymer
substrate surfaces which are difficult to adhere to.
[0026] Many inert surface materials have low surface energy. In the
present invention, media with surface tensions of a magnitude
differing from the surface energy of the substrate are selected in
order to perform the process of modifying this group of materials.
Optionally, for hydrophobic substrates, hydrophobic initiators and
hydrophilic media are selected. Most preferably, the medium, on the
one hand, and the substrate and the initiator, on the other hand,
have a sufficiently different hydrophilicity so that the reaction
will favor graft polymerization on the substrate instead of
homopolymerization in the medium. The properties of the modified
surface reflect the properties of the graft copolymer which in turn
depend on the monomers chosen. The monomers preferably are
sufficiently dissolved in the medium to permit the graft
polymerization reaction to occur. Alternatively, monomers can be
dispersed in the medium by suspension. Preferably, if the substrate
is hydrophilic, hydrophilic initiators are used, if hydrophobic,
preferably hydrophobic initiators are used.
[0027] The substrate can be of any suitable form or shape,
including but not limited to tubing, sheets, fibers, strips, films,
plates, filaments, pellet resins, powders, and extruded, molded or
cast articles. Optionally, the substrate can comprise a medical
device, including but not limited to catheters and drains. The
substrate can be hydrophobic or hydrophilic.
[0028] The method of the present invention preferably comprises
dissolving or dispersing one or more monomers in a medium
containing an appropriate solvent or solvent mixture. The substrate
or substrates are coated or otherwise contacted with the initiator,
such as a solution containing the initiator, and optionally then
dried. Optionally, the solution containing the initiator can
contain a small amount of polymer which is soluble in the medium to
adhere the initiator on the substrate temporarily. Preferably, the
initiator is coated or otherwise placed onto the substrate surface
prior to contacting the substrate with the medium. However, the
initiator optionally can be placed in the medium, either alone or
in conjunction with coating or otherwise placing it on the
substrate.
[0029] The monomer solution comprises suitable concentrations of
appropriate monomers, preferably at a concentration from about 2 to
about 6 w/w %, in a medium selected based on the properties of the
substrate and monomer. Preferably, an initiator-coated substrate is
placed in a reaction vessel which contains the monomer solution.
Optionally, the substrate, uncoated with initiator, can be placed
into a reaction vessel which contains the initiator in the medium.
Preferred reaction vessels include those having glass or stainless
steel surfaces.
[0030] Preferably, the system is degassed by vacuum to prevent air
bubbles forming between the reversed-phase substrate-solution
interface, and then the graft polymerization reaction is allowed to
proceed. However, degassing is not required. The presence of oxygen
is not believed to significantly affect the graft polymerization
reaction. Preferably, the reaction is conducted under an ambient
atmospheric gas mixture. However, the reaction can be conducted
under any suitable gas mixture, including nitrogen, argon, helium
and neon.
[0031] The graft polymerization reaction pressure preferably is
less than about 50 atmospheres, preferably from about 0.5 to about
50 atmospheres, more preferably from about 0.5 to about 10
atmospheres;, and even more preferably from about 0.75 to about 3
atmospheres. A reaction pressure of about 1 atmosphere is most
preferred.
[0032] The graft polymerization reaction preferably is conducted at
a temperature in the range from about from about 10.degree. C. to
about the boiling point of the medium solvent at the employed
pressure. At atmospheric pressure, using an aqueous solvent, the
reaction temperature preferably is less than about 100.degree. C.
More preferably, the reaction temperature is from about 40.degree.
C. to about 90.degree. C., and most preferably from about
80.degree. C. to about 90.degree. C., at atmospheric pressure. At
pressures higher than atmospheric, the reaction can take place at
higher temperatures. Suitable reaction times can range from about
ten minutes up to several hours, or longer. Monomer reactivity and
initiator decomposition are related to temperature. Generally, the
reaction rate is increased with increased temperature, allowing a
shorter reaction time. The upper limit of the reaction temperature
is governed by the boiling point of the medium, and the thermal
tolerance of the substrate, at the reaction pressure.
[0033] The process can be accelerated by removing any inhibitor
which was included with the monomer source to prolong monomer shelf
life, especially when high levels of inhibitors or low reactivity
monomers are used. However, generally it is unnecessary to remove
the inhibitor contained in the monomer.
[0034] Preferably, the medium is stirred during the time it is in
contact with the substrate to promote graft polymerization. If the
substrate is in the form of a hollow tube, or contains a lumen,
preferably the medium is pumped through the lumen in order to
promote graft polymerization of the interior surface or lumen of
the substrate. The reaction system often contains solid substrate
and liquid medium and in that sense is heterogeneous. Also,
differences in hydrophilicity between the medium and the substrate
can cause the heterogeneous nature of the system. Promoting
homogeneity of the medium and availability of monomers in the
region surrounding the substrate, e.g., by maintaining a relatively
uniform temperature, can contribute to the uniformity of the graft
coating. Therefore, moderate, continued stirring of the medium
preferably is maintained during the reaction. However, overly
vigorous stirring can slow graft polymerization, and is
disfavored.
[0035] After the reaction has been completed to a sufficient
degree, the substrate can be removed from reaction with the medium,
either by removing the substrate from the vessel, or by removing
the medium from the vessel. Any undesired monomers or polymers
remaining in the graft layer may be removed by washing. Although
initiators tend to remain attached to the substrate surface, they
can decompose at elevated temperatures and become smaller fragments
which can be removed easily. Any residual monomer, homopolymer,
initiator, and decomposed fragments of initiator which are present
on the substrate can be removed by washing in appropriate solvents
at elevated temperature, and discarded. Suitable washing solvents
include those which can dissolve monomers, homopolymers, initiator
or initiator fragments but do not deform the substrate.
[0036] Hydrophobic substrates useful in this invention include but
are not limited to solid synthetic or natural polymer materials.
The substrate preferably is a solid, but the invention can include
other suitable substrates, for example, cross-linked hydrogels. The
preferred solid substrate materials include, but are not limited
to: polyolefins, including but not limited to polyolefins such as
polyethylene and polypropylene, polyisobutylene and
ethylene-alphaolefin copolymers; silicone polymers; acrylic
polymers and copolymers, including but not limited to
polyacrylonitrile, polymethylmethacrylate, polyethylmethacrylate,
polyethylacrylate, and other polyesteracrylates and
polyestermethacrylates; fluoropolymers, including but not limited
to polytetrafluoroethylene, chlorotrifluoroethylene, fluorinated
ethylene-propylene, and polyvinyl fluoride; vinyl polymers,
including but not limited to polyvinyl chloride, polyvinyl methyl
ether, polystyrene, polyvinyl acetate, and polyvinyl ketones; vinyl
monomer-containing copolymers, including but not limited to ABS;
natural and synthetic rubbers, including but not limited to latex
rubber, butadiene-styrene copolymer, polyisoprene, polybutadiene,
butadiene-acrylonitrile copolymers, polychloroprene polymers,
polyisobutylene rubber, ethylene-propylenediene copolymers, and
polyisobutylene-isoprene; polyurethanes, including but not limited
to polyetherurethanes, polyesterurethanes, polycarbonateurethanes
and polysiloxaneurethanes; and polyamides, including but not
limited to Nylon 6, Nylon 66, Nylon 10, and Nylon 11; polyesters;
epoxy polymers; wool; cotton; silk; rayon; cellulose; and modified
celluloses.
[0037] Hydrophilic substrates preferably are solids and include,
but are not limited to: hydrophilic acrylic polymers, including but
not limited to polyacrylamide, poly-2-hydroxyethylacrylate,
poly-N,N'-dimethylacrylam- ide, polyacrylic acid, and
polymethacrylic acid; vinyl polymers, including but not limited to
poly-N-vinylpyrrolidone, and polyvinylpyridine; polymaleic acid;
poly-2-hydroxyethyl fumarate; maleic anhydride; starch and
polyvinyl alcohol.
[0038] The medium is selected according to the nature of the
substrate and the particular substrate surface modification
desired. The medium preferably does not appreciably dissolve the
substrate, and most preferably does not result in any dissolution
or swelling of the substrate. It is particularly preferred that the
medium and substrate have significant differences in their relative
hydrophilicity. For example, if a hydrophilic substrate is used, a
hydrophobic medium preferably is chosen and if a hydrophobic
substrate is used, a hydrophilic medium preferably is chosen. One
benefit of employing substrate and medium materials with different
relative hydrophilicity, such as materials with reversed phase
properties in terms of hydrophilicity, is that this can increase
the efficiency of generating substrate radicals. Also,
homopolymerization of the monomer can be limited by the lack of the
radicals in the medium. Although not wishing to be bound by theory,
it is believed that, as a result of differences in hydrophilicity
in the system, initiator radicals or organic propagating radicals
are directed to and attack the substrate, rather than the monomers
in the medium.
[0039] In a preferred embodiment, the invention includes a salting
out effect to favor graft polymerization. To employ a salting out
effect, materials, such as salts, that are characterized by
relatively high solubility in the medium are included in, or added
to, the medium to force the monomer(s) toward the substrate phase.
Preferred salting agents include, but are not limited to, sodium,
ammonium, and potassium salts.
[0040] In processes for modification of the surface of a
hydrophobic substrate, a hydrophilic media preferably is employed.
Aqueous solutions preferably are used as the media, more preferably
containing ion strength reinforcing agents. Preferably, ions or
buffers, including sodium, ammonium, potassium, chloride,
phosphate, and acetate are used. In processes for modifying
hydrophilic substrates, a hydrophobic medium preferably is used. In
such processes, the preferred media is an organic solvent,
preferably containing one or more of toluene, hexane, cyclohexane,
benzene, xylene, tetrahydrofuran, and aliphatic alcohols. Although
preferred, it is not necessary that the solvent be non-toxic.
[0041] The initiator should have an affinity for, and preferably
similar hydrophilicity to, the selected substrate, and should be
relatively insoluble or poorly soluble in the medium in order to
reduce homopolymerization in the medium. The initiator should be
capable of generating at least one, and preferably two or more,
free-radicals with an affinity for the substrate, permitting the
free radicals to attack the substrate surface to create functional
groups capable of reacting with the monomer.
[0042] If highly hydrophobic organic initiators with symmetrical
structures can generate two hydrophobic initiator free-radicals,
this class of initiators can have a higher efficiency of initiator
free-radical transference to the hydrophobic substrate than
initiators that generate only one hydrophobic initiator radical.
The insolubility or poor solubility of the initiator in the medium
can limit initiator free-radical diffusion into the medium, and
thereby inhibit initiation of homopolymerization of the monomers in
the medium. Initiators that can be used in the practice of the
present invention include, but are not limited to peroxides, azo
initiators, redox initiators, photo initiators and photosensitizers
which can be thermally initiated. Particularly preferred initiators
include organic peroxides.
[0043] Optionally, thermal initiators (including but not limited to
peroxide and azo initiators), and redox initiators can be used to
perform graft polymerization on inner surfaces of the substrate,
including but not limited to lumen surfaces if the devices
comprising the substrate are hollow. Under appropriate initiation
conditions, these initiators permit both the free radicals and
monomers in the liquid medium to access the lumen and to perform
graft polymerization. Thermal initiators can give relatively
constant initiation rates during the process, while the initiation
rate for redox initiators can decline quickly because of the rapid
consumption of initiator components. Initiation by radiation, with
and without proteolytic initiators, also can be useful in the
invention, although such initiators can be somewhat limited in
usefulness in lumens, since the penetration of the radiation
through the wall of the lumen reduces the intensity of the
radiation.
[0044] Preferred peroxide initiators include, but are not limited
to, peroxyesters, including but not limited to
1,1-dimethyl-3-hydroxybutyl peroxyneodecanoate, .alpha.-cumyl
peroxyneodecanoate, .alpha.-cumyl peroxyneoheptanoate, t-amyl
peroxyneodecanoate, t-butyl peroxyneodecanoate, t-amyl
peroxypivalate, t-butyl peroxypivalate, 2,5-dimethyl
2,5-di(2-ethylhexanoylperoxy)hexane, t-butylperoxy-2
ethylhexanoate, t-butylperoxyacetate, t-amylperoxyacetate,
t-butylperbenzoate, t-amylperbenzoate, and
t-butyl-1-(2-ethylhexyl)monope- roxycarbonate; peroxyketals,
including but not limited to,
1,1-di(t-butylperoxy)-3,3,5-trimethyl-cyclohexane,
1,1-di(t-butylperoxy)-cyclohexane,
1,1-di(t-amylperoxy)-cyclohexane,
ethyl-3,3-di(t-butylperoxy)-butyrate, and
ethyl-3,3-di(t-amylperoxy)-buty- lperoxy)-butylrate;
peroxydicarbonates, including but not limited to
di(n-propyl)peroxydicarbonates, di(sec-butyl)peroxydicarbonates,
and di(2-ethylhexyl)peroxydicarbonates; ketone peroxides, including
but not limited to 2,4-pentanedione peroxide; hydroperoxides,
including but not limited to cumene hydroperoxide, butyl
hydroperoxide, and amyl hydroperoxide; dialkyl peroxides, including
but not limited to dicumyl peroxide, dibutylperoxide, and
diamylperoxide; diacyl peroxide, including but not limited to
decanoyl peroxide, lauroyl peroxide, and benzoyl peroxide; and
inorganic peroxides, including but not limited to hydrogen peroxide
and potassium persulfate, and mixtures of the above.
[0045] Preferred azo initiators include but are not limited to
azobisisobutyronitrile, azobiscumene,
azo-bisiso-1,1,1-tricyclopropylmeth- ane,
4-nitrophenyl-azo-triphenylmethane, and
phenyl-azo-triphenylmethane. Preferred redox initiators include,
but are not limited to, peroxide-amine systems, peroxide-metal ion
systems, and boronalkyl-oxygen systems, such as are described in
Hans-Georg Elias, Macromolecules, Plenum Press (New York, 1984).
Photo initiators/photosensitizers which can be thermally initiated,
include, but are not limited to, organic peroxide and azo
initiators, benzophenone, benzophenone derivatives, and
camphorquinone-N,N dimethyl-amino-ethyl-methacrylate.
[0046] The monomers in the present invention preferably should be
selected so as to accomplish the desired graft polymerization
reaction, and to provide compatibility with the substrate, and to
impart the desired properties to the substrate. The term monomer is
used to refer to both monomeric and oligomeric forms of molecules.
Free radical polymerizable monomers or oligomers can be used in the
invention. Preferably, vinyl monomers, and more preferably acrylic
monomers, are used in the invention. To perform the graft coating
if the monomers used are relatively, or even completely, insoluble
in the medium, monomer suspensions could be made using dispersing
agents, including but not limited to polyvinyl alcohol, and barium
sulfate. Optionally, the addition of alcohol could increase the
solubility of the monomers, to achieve the desired concentration in
the medium.
[0047] Suitable hydrophilic monomers include, but are not limited
to, hydroxyl substituted ester acrylate and ester methacrylate,
including but not limited to 2-hydroxyethylacrylate, 2- and
3-hydroxypropylacrylate, 2,3-dihydroxypropylacrylate,
polyethoxyethyl-, and polyethoxypropylacrylates; acrylamide,
methacrylamide and its derivatives, including but not limited to
N-methylacrylamide, N,N-dimethylacrylamide,
N,N-dimethylmethacrylamide, N,N-dimethyl-aminoethyl,
N,.N-diethyl-aminoethyl, 2-acrylamido-2-methyl-1- -propanesulfonic
acid, N-[3-dimethylamino)propyl]acrylamide, and
2-(N,N-diethylamino)ethyl methacrylamide; polyethylene glycol
acrylates, polyethylene glycol methacrylates, polyethylene glycol
diacrylates, polyethylene glycol dimethacrylates; polypropylene
glycol acrylates, polypropylene glycol methacrylates, polypropylene
glycol diacrylates, polypropylene glycol dimethacrylates; acrylic
acid; methacrylic acid; 2- and 4-vinylpyridine; 4- and
2-methyl-5-vinylpyridine; N-methyl-4-vinylpiperidine;
2-methyl-1-vinylimidazole; dimethylaminoethyl vinyl ether;
N-vinylpyrrolidone; itaconic, crotonic, fumaric and maleic acids,
and mixtures thereof.
[0048] Hydrophobic monomers include, but are not limited to, ester
acrylates and ester methacrylates including but not limited to
methyl, ethyl, propyl, butyl, phenyl, benzyl, cyclohexyl,
ethoxyethyl, methoxyethyl, ethoxypropyl, hexafluoroisopropyl and
n-octyl-acrylates and -methacrylates; acrylamides and
methacrylamides; dimethyl fumarate, dimethyl maleate, diethyl
fumarate, methyl vinyl ether, ethoxyethyl vinyl ether, vinyl
acetate, vinyl propionate, vinyl benzoate, acrylonitrile, styrene,
alpha-methylstyrene, 1-hexene, vinyl chloride, vinyl methyl ketone,
vinyl stearate, 2-hexene and 2-ethylhexyl methacrylate, and
mixtures thereof.
[0049] Optionally, cross-linking agents can be used to provide a
cross-linked polymer structure. Suitable agents include, but are
not limited to, monomers having di- or multi-unsaturated functional
groups, including but not limited to diacrylates and
dimethylacrylates of -polyethylene glycol and -polypropylene
glycol, trimethylolpropane triacrylate and trimethacrylate,
di-trimethylolpropane, tetraacrylate, pentaerythritol
tetraacrylate, and tetramethacrylate, divinylbenzene, divinyl
sulfone silicone-containing diacrylates and dimethacrylates.
[0050] Many polymeric polymer devices are made of polymers, such as
silicone rubber, polyethylene, and polypropylene, which have a
hydrophobic surface. In many applications for these devices, it is
desirable that the device have a hydrophilic, lubricious surface.
For example, catheters used in angioplasty and angiographic
procedures preferably are lubricious and hydrophilic, to promote
ease of transport from the point of insertion to the desired
position for imaging or treatment, such as a cardiac ventricle.
With the invention, hydrophilic monomers, such as
N-vinylpyrrolidone, acrylamide and derivatives, can form wet
lubricious polymer coatings on the surface of a hydrophobic medical
device, by reversed phase graft polymerization. Since the present
invention allows the monomer solution to contact the inner lumen of
hollow devices, lumen surface modification is readily
performed.
[0051] With the invention, monomers substituted containing
functional groups can be used, to provide functional groups on the
polymer surface. Two significant applications for providing such
functional groups on the polymer surface are to attach
physiologically or pharmacologically active agents to the polymer
and to employ the graft polymer as a tie coat for other coatings
which otherwise might not adhere to the substrate. With the present
invention, graft polymers can be created which contain functional
groups to which biological agents such as penicillins,
cephalosporins, fluoroquinolones, aminoglycosides, silver
compounds, phenols, and biguanides can be attached. Monomers having
functional groups including, but not limited to, carboxylic acid,
amine, hydroxyl, and polyethylene glycol could be used in order to
provide these functional groups on the surface after graft
coating.
[0052] With the invention, monomers may also be used that may or
may not contain functional groups and which can serve to provide
the surface with properties such as wet lubricity, hardness,
softness, or other physical properties. Such graft layers may also
be used as a reservoir so that materials, such as drugs, can be
entrapped in the graft layer and can be leached out when placed in
moist environments, such as inside human patients. This can provide
targeted drug delivery to various sites within the body. Typical
drugs which can be entrapped within the graft layers include, but
are not limited to, anti-infective agents, such as antibiotics
(including aminoglycosides such as gentimicin and amikacin),
antimicrobial agents, such as benzalkonium chloride,
2-bromo-2-nitropropane-1,3-diol (Cosmosil), and polyhexanide
(Bronopol); antithrombogenic compounds, such as
benzalkoniumheparinate, and trididecylmethylammonium heparinate;
anticancer agents, such as paclitaxel, merbarone, and methotraxate;
anti-inflammatories, such as dexamethasone; and other agents as may
be desired. In this way, the agents may be entrapped with or
without covalent interactions with functional groups that may or
may not exist on the graft polymer(s), and one or both mechanisms
(entrapment and covalent bonding) could be operating within a layer
simultaneously. Also, the graft polymers can act as tie coats to
other layers which can serve as drug reservoirs.
[0053] Since the coating is covalently bonded to the substrate, the
surface coating in the present invention has strong adhesion to the
substrate. The yield of graft polymer can be controlled, by
changing the surface area and factors such as initiation rate,
temperature, and monomer concentration, which influence molecular
weight in traditional free radical polymerization. Accordingly, the
amount and size of side chains can be controlled with the
invention.
[0054] A preferred embodiment of the present invention comprises
treating a silicone substrate by dip-coating the substrate with an
initiator comprising an organic peroxide solution, preferably a 1
to 10% solution, in tetrahydrofuran (THF). Thereafter, the
substrate is air-dried and placed in a medium comprising about 3.9
w/w % N,N-dimethylacrylamide and about 0.19 w/w % acrylamide, about
0.25 w/w % diacrylate crosslinker, about 15% w/w sodium chloride
and about 0.02 w/w % polyvinylpyrrolidone. The system is optionally
degassed and the reaction is performed at a temperature from about
20.degree. C. to about 100.degree. C., more preferably from about
80.degree. C. to about 90.degree. C., most preferably from about
85.degree. C. to about 89.degree. C., and at a pressure from about
0.5 atmospheres to about 50 atmospheres, more preferably from about
0.5 atmospheres to about 3 atmospheres. The reaction preferably is
permitted to proceed for up to about 3 hours while there is gentle
mixing of the medium by a magnetic stirrer. This system provides
graft layers of reasonable smoothness on the substrate surface; a
longer reaction could produce thicker, rougher coats.
[0055] Another preferred embodiment of the present invention
comprises coating a silicone substrate with an initiator comprising
organic peroxide solution, at a concentration of about 1 to 10 w/w
%, preferably about 6 w/w %, in tetrahydrofuran (THF). The
substrate can be air dried and then placed into a medium comprising
1.9 w/w % acrylamide, 4.3 w/w % polyethylene glycol acrylate, 14.5
w/w % sodium chloride, and 2.0 w/w % polyvinylpyrrolidone. The
reaction is performed at a temperature from about 20.degree. C. to
about 100.degree. C., more preferably from about 80.degree. C. to
about 90.degree. C., most preferably from about 85.degree. C. to
about 89.degree. C., and at a pressure from about 0.5 atmospheres
to about 50 atmospheres, more preferably from about 0.5 atmospheres
to about 3 atmospheres. At a temperature of about 85.degree. C. to
about 89.degree. C., and a pressure of about 1 atmosphere, the
reaction is permitted to proceed for up to about 50 minutes while
there is gentle mixing of the medium.
[0056] In another preferred embodiment, reverse phase graft
polymerization is used to produce a surface coating on a substrate
for use as a primer, or tie coat. A preferred method includes
coating a substrate, such as a silicone substrate with an initiator
comprising organic peroxide solution, about 1 to 10 w/w %,
preferably about 6 w/w %, in tetrahydrofuran (THF), followed by
dip-coating in a solution comprising 1 w/w % polyurethane, 12%
acrylic polymer, 1.2% epoxy polymer, 64.1% THF, 10.2% methyl ethyl
ketone, 10% ethylene glycol monobutyl ether and 1.5% polyethylene
glycol, and then drying, preferably at about 85.degree. C. for up
to about 4 hours.
[0057] In another preferred embodiment, non-reverse phase graft
coating is used to produce a surface coating on a difficult to
adhere to substrate for use as a primer, or tie coat. A preferred
method could include coating a substrate, such as a silicone
substrate with an initiator comprising organic peroxide such as
benzoyl peroxide, 1 to 10 w/w % in tetrahydrofuran, allowing to air
dry. The treated substrate could then be dipped in a solution
comprising 10 to 15 w/w % acrylic monomer(s) in 64.1% THF, 10.2%
methylethylketone, 1.5% polyethylene glycol, 5%
hydroxyethylmethacrylate, and the balance ethylene glycol monobutyl
ether at 60.degree. C., for a period of four hours in a reflux
condenser. This would produce a graft polymer layer on the silicone
surface to which various polymer coatings would adhere well. Such
polymer layers would include but not be limited to polyurethanes,
acrylics, polyamides, cellulosics and others.
[0058] The following Examples are illustrative of the invention,
and are not intended to limit the scope of the invention.
EXAMPLE 1
[0059] Medical-grade colorless silicone tubing (Helix Medical, 3.18
mm outer diameter.times.1.58 mm internal diameter.times.20 cm
length), was first treated by standard dip-coating in an 8 w/w %
benzoyl peroxide solution in tetrahydrofuran (THF) for 30 seconds.
The tubing was air dried and then placed in a 6 cm.times.40 cm
glass cylinder, open at one end, containing 800 gm of an aqueous
monomer solution composed of 3.9 w/w % N,N-dimethylacrylamide and
0.19 w/w % acrylamide, 0.25 w/w % diacrylate crosslinker, 15 w/w %
sodium chloride and 0.02 w/w % polyvinylpyrrolidone. The system was
degassed at 1.0 mm Hg for 10 minutes. The reactor was placed in a
water bath at 87.degree. C. for 3 hours, and the reaction system
was stirred gently on a magnetic stirrer. After 3 hours, the tubing
was removed from the reactor and washed with water.
[0060] The treated tubing was tested for lubricity. This coating
was strongly adherent to the substrate and decreased the
coefficient of friction to 6.8% of the original coefficient, from
183 g for the uncoated substrate to 12.5 g after coating, when the
samples were pulled with 70.8 g weight against polyvinyl chloride
under deionized water.
1TABLE 1 Contact angles (.theta.) of graft coated silicone rubber
and silicone rubber control Samples Control Graft Coating
Measurement Advancing .theta. Receding .theta. Advancing .theta.
Receding .theta. Run 1 108.36 78.08 103.9 26.68 Run 2 109.22 81.63
101.26 28.33 Run 3 107.99 78.02 106.66 37.74
[0061] A sample of the graft-coated tubing also was dipped in 2.0
w/w % of solution of gentian violet in water and alcohol, then
taken out immediately and rinsed under a running tap of deionized
water for 5 minutes. Following the rinse, the coating had a blue
staining indicating a hydrophilic surface.
EXAMPLE 2
[0062] Medical-grade colorless silicone tubing (Helix Medical, 3.18
mm outer diameter.times.1.58 mm internal diameter.times.20 cm
length), was treated by standard dip-coating in 8 w/w % benzoyl
peroxide in tetrahydrofuran (THF) for 30 seconds. The tubing was
air dried and then placed in a 6 cm.times.40 cm glass cylinder,
open at one end containing 800 gm of an aqueous monomer solution
composed of 1.9 w/w % acrylamide, 4.3 w/w % polyethylene glycol
acrylate, 14.5 w/w % sodium chloride and 2.0 w/w %
polyvinylpyrrolidone. The system was degassed at 1.0 mm Hg for 10
minutes. The reactor was placed in a water bath at 87.degree. C.
for 50 minutes and the reaction system was stirred gently on a
magnetic stirrer. After 50 minutes the tubing was removed from the
reactor and washed with water.
[0063] A sample of the tubing was stained using the method
described in Example 1, and showed a blue staining which indicated
the presence of a hydrophilic surface on the substrate. After
drying, the sample then was elongated up to 350%. After elongation,
the sample returned to its original configuration with no evidence
of cracking, crumbling, or delamination, and the visual appearance
of the sample remained the same as prior to elongation.
[0064] The graft coated and stretched sample of the tubing was
tested for graft adhesion. A strip of adhesive tape (Scotch tape
(3M)) was pressed firmly over the sample and removed quickly. No
blue coating spots adhered to the tape.
[0065] Unstretched coated samples were soaked for 5 minutes in
aqueous solutions containing antimicrobial agents with w/w
concentrations as shown in Table 2, and then rinsed with deionized
water. They were air dried and then incubated for 24 hours at
37.degree. C. on standard method agar against S. aureus, and
evaluated by zone of inhibition. The inhibition zone diameter of
the treated samples against S. aureus is given in Table 2.
2TABLE 2 Inhibition zone diameter (four runs) against S. aureus
Zone size (mm) Uncoated silicone tubing Graft coated silicone
Antimicrobial (control) tubing 4.8% rifamycin 17, 19, 20, 26 32,
33, 33, 35 1.9% gentamicin lauryl Not tested 12, 12, 12, 13 sulfate
2% vantocil 0, 0, 0, small 9, 9, 10, 10 4.8% benzalkonium 0, 0,
small, small 16, 16, 16, 16 chloride 2% 2-bromo-2- Not tested 38,
38, 38, 38 nitropropane-1,3-diol 2% silver nitrate Not tested 11,
12, 12, 12 2% Germall plus Not tested 8, 8, 8, 8 1% methotraxate
Not tested 10, 11, 11, 11 1% paclitaxel Not tested 6, 6, 6, 7
EXAMPLE 3
[0066] Interior coated samples made according to Example 1 were
placed in a monomer solution made according to Example 2, composed
of 1.9 w/w % acrylamide, 4.3 w/w % polyethylene glycol acrylate,
14.5 w/w % sodium chloride, and 2.0 w/w % polyvinylpyrrolidone. A
graft polymerization reaction was performed using the procedure set
forth in Example 1, except that instead of stirring, the reaction
solution was circulated vertically upwardly through the tubing by a
roller pump. After 50 minutes the tubing was removed from the
reactor, and washed with water.
[0067] A sample of the tubing was stained using the method
described in Example 1, and a blue color on the interior surface of
the tubing indicated the presence of the coating on the inner
surface of the tubing.
EXAMPLE 4
[0068] Initiator-coated samples made according to Example 1 and
silicone tubing samples without initiator coating were placed in a
monomer solution made according to Example 2. Graft polymerization
was performed according to the procedure used in Example 1. After
graft polymerization, the samples that were not coated with
initiator were rinsed and stained using the method of Example 1.
The blue dyed surface indicated the presence of the graft coating
on these samples. This demonstrates that initiator can diffuse
through the medium and cause graft polymerization without inducing
significant homopolymerization
EXAMPLE 5
[0069] Samples cut from a latex rubber glove (VWR Scientific
Products, Inc.) were dip-coated with an initiator solution, in the
same method set forth in Example 1. Then, graft polymerization was
performed using an aqueous monomer solution composed of 1.9 w/w %
acrylamide, 4.3 w/w % of polyethylene glycol acrylate, 14.5 w/w %
sodium chloride, and 2.0 w/w % polyvinylpyrrolidone, using the
procedures set forth in Example 1. After polymerization, the
samples were stained as described in Example 1. The blue stain
demonstrated that a graft coating was obtained.
EXAMPLE 6
[0070] Pieces of polyurethane tubing (Thermedics Inc.) were graft
coated using the method described in Example 5. The coated samples
were stained according to the method of Example 1. The significant
blue staining demonstrated that graft coating on the surface.
EXAMPLE 7
[0071] Pieces of polyethylene tubing were dip-coated with an
initiator solution comprising 8 w/w % benzoyl peroxide in
tetrahydrofuran (THF) for 30 seconds. The tubing was air dried and
then placed in a long reactor containing an aqueous medium
comprising 30.0 w/w % acrylamide, 2.0 w/w % polyvinylpyrrolidone,
15.0 w/w % sodium chloride. The system was degassed at 1.0 mm Hg
for 10 minutes. The reactor was placed in a water bath at
85.degree. C. for 40 minutes and the reaction system was stirred
gently on a magnetic stirrer. After 40 minutes the tubing was
removed from the reactor and washed with water. The sample was
stained according to the method described in Example 1, which
indicated a hydrophilic coating on the surface.
EXAMPLE 8
[0072] Samples of medical-grade colorless silicone tubing (Helix
Medical, 3.18 mm outer diameter.times.1.58 mm internal
diameter.times.20 cm length) were treated according to the method
described in Example 2. The dry tubing samples were dip-coated in a
solution comprising 1 w/w % polyurethane, 12% acrylic polymer, 1.2%
epoxy polymer, 64.1% THF, 10.2% methyl ethyl ketone, 10% ethylene
glycol monobutyl ether and 1.5% polyethylene glycol, and then dried
at 85.degree. C. for 4 hours. An adhesion test was conducted
according to the method of Example 1, and the samples passed the
test.
EXAMPLE 9
[0073] A piece of medical grade Tygon tubing (polyvinylchloride)
was graft-coated according to Example 1. The sample was then stain
tested according to Example 1, and the staining demonstrated the
presence of a hydrophilic graft-coating of the sample surface.
* * * * *